Why this matters — Three distinct ORTEX data streams have moved simultaneously on BAC: short interest spiked then partially reversed, cost to borrow collapsed 62% in a week, and the put/call ratio hit a 2.4 standard-deviation extreme. The signals point in different directions, making the current setup unusually complex for the $52 mega-cap bank.
Short Interest — Up Then Easing Short interest jumped 14% in late March, peaking near 110 million shares. It has since pulled back. As of April 24, shares short stand at ~100.7 million — still up 9.7% over the past month. At 1.38% of free float, the level is moderate by historical standards. The 52-week range runs from roughly 79 million to 115 million shares, placing current positioning in the middle of that band.
Cost to Borrow — Sharp Drop CTB plummeted to 0.14% on April 24. That is down 62% from 0.38% a week ago and down 53% over the past month. The rapid decline suggests short sellers are returning borrowed shares or that lending supply has risen. Either way, the urgency to maintain short positions has visibly dropped.
Put/Call Ratio — Elevated Hedging The PCR stands at 1.33, against a 20-day mean of 1.19. The z-score of 2.43 places it well above the recent range. Options traders are holding significantly more puts than usual relative to calls. The 52-week PCR high is 1.67, so current levels are elevated but not extreme.
Analysts moved swiftly post-earnings. Following the April 15 print, Piper Sandler, Oppenheimer, Evercore ISI, Truist, and KBW all raised price targets. The consensus target sits at $62.80 — implying roughly 21% upside from the current $52.05 close. Capital Research added 41.3 million shares in Q1, the largest institutional build among top holders. Berkshire Hathaway trimmed 50.8 million shares as of December 2025, however, a notable contrast. Insiders sold net across the period reviewed, with CEO Brian Moynihan selling ~18,000 shares on April 15 alongside an award of the same size — a routine pattern. The ORTEX short score of 31 is low, consistent with the modest utilisation reading of 0.85%.
Short interest peaked at 114.9 million shares in December 2025, when days to cover reached 3.36. The March–April 2026 spike to ~110 million followed a similar structure — a sharp build followed by rapid unwind. The current CTB decline mirrors the post-December easing, where borrow costs also quickly normalised after the peak.
See the live data behind this article on ORTEX.
Open BAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
